Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Reexamination Certificate
2007-01-30
2007-01-30
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
C435S947000
Reexamination Certificate
active
09840485
ABSTRACT:
The present invention provides an immunogenically active component comprising inactivatedSarcocystis neuronacells and/or inactivatedNeospora hughesicells; antigens derived therefrom; DNA derived therefrom; or a mixture; or in combination with other vaccine components; thereof. Further provided are vaccine compositions useful for preventing or ameliorating equine protozoal myeloencephalitis infection and disease and a method for the cell culture propagation of protozoan parasites.
REFERENCES:
patent: 5554371 (1996-09-01), Caputa et al.
patent: 6071737 (2000-06-01), Marsh et al.
patent: 6110665 (2000-08-01), Fenger et al.
patent: 6153394 (2000-11-01), Mansfield et al.
patent: 6344337 (2002-02-01), Mansfield et al.
patent: 6489148 (2002-12-01), Mansfield et al.
patent: 2310135 (1997-06-01), None
patent: 2310212 (1997-08-01), None
patent: 97/29120 (1997-08-01), None
patent: WO 97/29770 (1997-08-01), None
patent: WO 99/47927 (1999-11-01), None
patent: WO 00/17640 (2000-03-01), None
patent: WO 00/49049 (2000-08-01), None
patent: WO 01/15708 (2001-03-01), None
patent: WO 01/15708 (2001-08-01), None
Granstrom, D.E. et al.“Equine Protozoal Myloencephalitis” Journal Veterinary Diagnostic Investigation vol. 5, pp. 88-90, 1993.
Mrash,A.E. et al. “Description of a New Neospora Species” Journal of Parasitology, vol. 84, No. 5, pp. 983-991, 1998.
Granstrom, D.E. et al.“Equine Protozoal Myloencephalitis” Journal Veterinary Diagnostic Investigation vol. 5, pp. 88-90, 1993.
Boslego, JW et al (1991), Chapter 17, p. 211-223, in Vaccines and immunotherapy.
Ellis, Ronald W., Ph.D., Chapter 29, pp. 568-575, New Technologies for making vaccines, in Vaccines, 1988, WB Saunders Company, Plotin and Mortimer.
Granstrom, DE et al, J. Vet. Diagn. Invest., vol. 5, pp. 88-90, 1993, Equine protozoal myeloencephalitis: antigen analysis of culturedSarcocystis neuronamerozoites.
Dubey, JP et al, J. Eukaryot. Microbiol. 1999, Sep.-Oct. vol. 46(5), pp. 500-506, Characterization of aSarcocystis neuronaisolate (SN6) from a naturally infected horse from Oregon.
Dubey, JP et al, JAVMA, vol. 215, No. 7, pp. 970-972, Oct. 1, 1999, Serologic pervalence ofSarcocystis neurona,Toxoplasma gondiiandNeospora caninumin horses in Brazil.
Dubey, JP et al, Vet. Parasitol. 1999, Sep. 15, vol. 86(1), pp. 59-62, Prevalence of antibodies toSarcocystis neurona,Toxoplasma gondiiandNeospora caninumin horses from Argentina.
Murphy, AJ et al, J. Parasitol. Oct. 1999; vp;/ 85(5), pp. 979-981, Simplified technique for isolation, excystation and culture ofSarcocystisspecies from opossums.
Liang, FT et al, Infection and Immunity, vol. 66(5), pp. 1834-1838, May 1998, Evidence that surface proteins Sn14 and Sn16 ofSarcocystis neuronamerozoites are involved in Infection and Immunity.
Liang, Fang Ting et al, Analytical Biochemistry, vol. 250, pp. 61-65, 1997, Micropreparative high resolution purification of proteins by combination ofSodium dodecylsulfate polyacrylamide gel electrophoresis, isoelectric focusing and membrane blotting.
Rossano, MG et al, J. Vet. Diagn. Invest. vol. 12, pp. 28-32, 2000, Improvement of western blot test specificity for detecting equine serum antibodies toSarcocystis neurona.
Sep. 2002, Wyeth 2002 Medical Device Company, abstract, from Pharaceutical Companies analysis, title “Structure and activities”.
US conditional approval for Fort Dodge equine vaccine, Animal-Pharm, vol. 464, p. 18, Mar. 9, 2001 (abstract only).
Gradoni, L et al, Vaccine, vol. 23, 2005, pp. 5245-5251.
Hagan, Paul et al, Expert. Opinion Biol. Ther. 2003, vol. 3(8), pp. 1271-1278.
Andrianarivo, AG et al, International Journal of Parasitology, vol. 30, 2000, pp. 985-990.
Pye, D et al, Infection and Immunity, vol. 59(7), pp. 2403-2411, Jul. 1991.
Cheadle et al., Int'l Journal for Parasitology 31 (2001) 330-335, The nine-banded armadillo (Dasypus novemcinctus) is an intermediate host forSarcocystis neurona.
Paola Minoprio, Int'l Journal for Parasitology 31 (2001) 588-591, Parasite polyclonal activators: new targets for vaccination approaches?.
Saville et al., Verterinary Parasitology 95 (2001) 211-222, Utilization of stress in the development of an equine model for equine protozoal myelocephalitis.
Lindsay, et al., Veterinary Parasitology 95 (2001) 179-186, Direct agglutination test for the detection of antibodies toSarcocystis neuronain experimentally infected animals.
Cheadle et al., Veterinary Parasitology 95 (2001) 305-311, Sporocyst size of isolates of Sarcocystis shed by the Virginia opossum (Didelphis virginiana).
J. P. Dubey, Veterinary Parasitology 95 (2001) 341-351, Migration and development ofSarcocystis neuronain tissues of interferon gamma knockout mice fed sporocysts from a naturally infected opossum.
Porter, et al., Veterinary Parasitology 95 (2001) 313-319, Evaluation of the shedding ofSarcocystis falcatulasporocysts in experimentally infected Virginia opossums (Didelphis virginiana).
Dubey et al., Veterinary Parasitology 95 (2001) 283-293, Prevalence ofSarcocystis neuronasporocysts in opossums (Didelphis virginiana) from rural Mississippi.
Mansfield et al., Veterinary Parasitology 95 (2001) 167-178, Comparison ofSarcocystis neuronaisolates derived from horse neural tissue.
Cook, et al., Veterinary Parasitology 95 (2001) 187-195, Interpretation of the detection ofSarcocystis neuronaantibodies in the serum of young horses.
Vardeleon et al., Veterinary Parasitology 95 (2001) 273-282, Prevalence of Neospora hughesi andSarcocystis neuronaantibodies in horses from various geographical locations.
Cutler et al., Veterinary Parasitology 95 (2001) 197-210, Immunoconversion againstSarcocystis neuronain normal and dexamethasone-treated horses challenged withS. neuronasporocysts.
Cutler, et al., J. Parasitology 85(2) 1999 301-305, AreSarcocystis neuronaandSarcocystis falcatulasynonymous? A horse infection challenge.
Rossano et al., J Vet Diagn Invest 12:28—32 (2000), Improvement of western blot test specificity for detecting equine serum antibodies toSarcocystis neurona.
Gauthier et al., J Vet Diagn Invest 11:259-265 (1999), Western immunoblot analysis for distinguishing vaccination and infection status withBorrelia burgdorferi(Lyme disease) in dogs.
Lindsay, et al., J Parasitology 86(1) 2000 164-166, Determination fo the Activity of Diclazuril AgainstSarcocystis neuronaandSarcocystis falcatulain Cell Cultures.
Dubey et al., J Parasitology 86(1) 2000 160-163, Isolation ofSarcocystis speeriDubey and Lindsay, 1999 Parasite from the south American Opossum (Didelphis albiventris) from Argentina.
Reed et al., AAEP Proceedings vol. 42 1996 75-78, Equine Protozoal Encephalomyelitis.
Dubey et al., J Parasitology 86(6) 2000 1276-1280, Completion of the Life Cycle ofSarcocystis neurona.
Dubey et al., J Parasitology 86(5) 2000 1150-1152, Immunohistochemical Confirmation ofSarcocystis neuronaInfections in raccoons, Mink, Cat, Skunk, and Pony.
Dame et al., Parasitol Res 2000 86: 940-943, Equine protozoal myeloencephalitis: msytery wrapped in enigma.
Saville et al., JAVMA vol. 217 No. 8, 2000,1174-1185, Analysis of risk factors for the development of equine protozoal myeloencephalitis in horses.
Dubey et al., J Parasitology 84(16), 1998 1158-1164, Isolation of a Third species of Sarcocystis in Imunodeficient mice fed Feces from Opossums (Didelphis virginiana) and its Differentiation fromSarcocystis falcatulaandSarcocystis neurona.
Cutler et al., J Parasitology 85(2) 1999 301-305, AreSarcocystis neuronaandSarcocystis falcatlulaSynonymous? A horse Infection Challenge.
Dubey et al., J Eukaryot. Microbiol. 46(5) 1999 500-506, Characterization of aSarcocystis neuronaIsolate (SN6) from a Naturally Infected Horse from Oregon.
Fenger et al., Veterinary Parasitology 68 (1997) 199-213, Experimental induction of equine protozoal myeloencephalitis in horses usingSarcocystissp. Sporocysts from the opossum (Didelphia virginiana).
Clara K. Fenger, Parasitology vol. 19, No. 4, Apr. 1997, 513-523, Equine Protozoal Myeloencephalitis.
Kisthardt et al., Equine Practice, vol. 19, No. 2, Feb. 1997, 8-13, Equine Protozoal M
Bigbie Rocky Barry
Ng Terry Kaleung
Whalen, Jr. Joseph Wilson
Mandel Adley F.
Navarro Mark
Portner Ginny Allen
Rosenblum Anne M.
Wyeth
LandOfFree
Equine protozoal myeloencephalitis vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Equine protozoal myeloencephalitis vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Equine protozoal myeloencephalitis vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3769397